logo
Select company
Select metric
2.8Debt to Equity Ratio
VS
Market
28
Sector
13
Industry
10
History
-
$ 11.68Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Debt to Equity Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - D/E Historical data
DateDebt to Equity RatioShareholders EquityTotal Liabilities
6/30/20252.8$ 79.28M$ 221.75M
3/31/20252.45$ 93.54M$ 229.46M
12/31/20242.12$ 111.82M$ 236.83M
9/30/20241.92$ 128.81M$ 247.84M
6/30/20241.68$ 148.91M$ 249.91M
3/31/20241.49$ 166.11M$ 247.44M
12/31/20231.23$ 191.88M$ 236.62M
9/30/20231.13$ 216.74M$ 245.54M
6/30/20231.08$ 237.82M$ 257.35M
3/31/20230.21$ 269.38M$ 57.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) D/E stands at 0.07.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average D/E has been 0.86.
  • The median D/E for ENANTA PHARMACEUTICALS INC during this period was 0.19
  • ENANTA PHARMACEUTICALS INC reached its highest D/E over the past 5 years at 2.8.
  • The lowest D/E recorded by ENANTA PHARMACEUTICALS INC in the same timeframe 0.06

ENANTA PHARMACEUTICALS INC's D/E vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

D/E Benchmarks
CompanyD/E
THTX : THERATECHNOLOGIES INC -BDTX : BLACK DIAMOND THERAPEUTICS INC 0.25PLX : PROTALIX BIOTHERAPEUTICS INC 0.57ALEC : ALECTOR INC 4.01SGMO : SANGAMO THERAPEUTICS INC 3.98CSBR : CHAMPIONS ONCOLOGY INC 7.7SPRO : SPERO THERAPEUTICS INC 0.89CCCC : C4 THERAPEUTICS INC 0.7TRDA : ENTRADA THERAPEUTICS INC 0.18CELU : CELULARITY INC -

Definition of Debt to Equity Ratio

[Calculation] Debt to Equity (D/E) measures the ratio between a company’s [Liabilities] and [Equity]. A high ratio might indicate more risk.
Liabilities / Equity
(=) D/E
D/E for ENANTA PHARMACEUTICALS INC is calculated as follows: Liabilities [ $ 30.55M ] / Equity [ $ 455.58M ]
(=) D/E [ 0.07 ]

ENTA - Debt to Equity Ratio, Last 5 years

0.06

Minimum

Dec 31, 2020

2.8

Maximum

Jun 30, 2025

0.86

Average

0.19

Median

D/E Benchmark Analysis

The chart above depicts the distribution of D/E for companies in the Total Stock Market. The average D/E of the companies is 1.4 with a standard deviation of 1.31.
The following table provides additional summary stats:
D/E in the Market:
filtered constituents3.3K
min0
max6.06
average1.4
median0.98
std1.31